Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,516.27 98.74 0.68%
TOPIX 1,173.37 6.78 0.58%
HANG SENG 22,760.24 64.23 0.28%

Pharma CEOs Address Dermatology Community at At Orlando Dermatology Aesthetic & Clinical Conference

Pharma CEOs Address Dermatology Community at At Orlando Dermatology Aesthetic
                            & Clinical Conference

PR Newswire

ORLANDO, Fla., Jan. 22, 2013

ORLANDO, Fla., Jan. 22, 2013 /PRNewswire/ -- With record-breaking attendance
of over 800 attendees, the Orlando Dermatology Aesthetic & Clinical (ODAC)
conference proudly welcomed three leading executive officers to its 10th
annual program, which opened yesterday at the Omni ChampionsGate in Orlando,

To kick off the conference, BILL HUMPHRIES, President & CEO, MERZ, INC.,  JOHN
CEO, VALEANT PHARMACEUTICALS INTERNATIONAL offered their unique perspectives
on the future of dermatology during an exclusive keynote panel address lead by
Conference Chair James Spencer, MD, MS, Director, Spencer Dermatology & Skin
Surgery Center.

Of many topics, the executives offered these comments regarding the importance
of understanding the changing landscape for resident physicians today. Bill
Humphries, President & CEO, Merz, Inc. noted, "Educating and providing product
services to residents is critical.  As a company, we are vested in working
with the Chairs of these institutions to find a compliant and effective way to
provide not only products and services, but, an appropriate exchange of
scientific information to meet the needs of these future dermatologists." 

John Koconis, President & CEO, Leo Pharma, Inc. stressed the importance of
"patient-centricity;" adding, "There is a better way, and what that means is
focusing around the needs of the patient."

J. Michael Pearson, Chairman and CEO, Valeant Pharmaceuticals International,
continued, "We are a business. We look for performance and put money against
the things that help us help you with your business."

ODAC commenced on January 21, 2013. Now concluding its tenth successful year,
the ODAC conference provides a balance of medical and aesthetic training,
delivering a comprehensive and compelling look at the practice of dermatology.
Through interactive workshops, live demonstrations, and presentations from top
industry leaders, ODAC uses a state-of-the-art audience response
system, unrivaled in similar industry meetings, that adds an element of
excitement and interactivity—all while providing Continuing Medical Education
(CME) credits to conference delegates.

The ODAC conference is produced by SanovaWorks, a Manhattan based healthcare
communications company, with its flagship enterprise in the dermatology space.

Media Contact:

Amy Wilder

Senior Marketing Associate, SanovaLive Lead

(646) 736-4334

SOURCE SanovaWorks

Sponsored Links
Sponsored Links